Twist Bioscience Corp
Financial highlights
| Metric | FY 09/30/25 | FY 09/30/24 | FY 09/30/23 | FY 09/30/22 | FY 09/30/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $376.6 | $313.0 | $245.1 | $203.6 | $132.3 |
| Operating income | -$136.3 | -$220.8 | -$217.2 | -$234.8 | -$152.7 |
| Net income | -$77.7 | -$208.7 | -$204.6 | -$217.9 | -$152.1 |
| Balance Sheet | |||||
| Total debt | — | — | — | — | $0.8 |
| Cash Flow Statement | |||||
| Free cash flow | -$75.6 | -$69.2 | -$170.3 | -$226.2 | -$139.3 |
Shares outstanding 62.7M · Free float 96.9%
Annual filing data through FY ended September 30, 2025; float as of September 30, 2026.